COMMUNIQUÉS West-GlobeNewswire

-
Legend Senior Living® Grows Portfolio Across Kansas, Colorado, and Pennsylvania
30/05/2025 -
PharmAla Biotech Warns Against Fake Products Claiming to be Made by PharmAla
30/05/2025 -
Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting
30/05/2025 -
Specific Health Guidance Service Utilizing the "Lav" Healthcare App: Surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals!
30/05/2025 -
Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
30/05/2025 -
Hapbee Launches Redesigned Mobile App with AI-Powered Discovery Engine, Expanded Vibe Library and Real-Time In-App Support to Enhance Personalization, Usability, and User Engagement
30/05/2025 -
Radical Clean Solutions Ltd. Terminates Asset Purchase Agreement with AgriForce Growing Systems Ltd. and Files Lawsuit for Breach of Contract
30/05/2025 -
CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference
30/05/2025 -
Shareholder Update
30/05/2025 -
Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer
30/05/2025 -
Noom Launches Free Menopause Education Hub in Partnership with Menopause Advocate Tamsen Fadal
30/05/2025 -
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference
30/05/2025 -
Spectral AI Announces Appointment of Stanley Micek as Chief Operating Officer
30/05/2025 -
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
30/05/2025 -
Femasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 Million
30/05/2025 -
Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics
30/05/2025 -
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
30/05/2025 -
Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
30/05/2025 -
Appili Therapeutics Announces Formal Termination of Arrangement Agreement with Aditxt Inc.
30/05/2025
Pages